Intermittent fasting cuts weight but may raise LDL and cost lean mass

Intermittent fasting has become one of the most popular strategies for managing weight and improving cardiometabolic health, yet most of the evidence treats adults as one homogeneous group. Bodies change with age: how muscle is preserved, how insulin behaves, how blood lipids respond. Whether a twenty-something and a sixty-something get the same benefits, or run the same risks, from the same fasting pattern has been unclear. This review set out to map the effects of intermittent fasting on body composition and cardiometabolic markers separately across adult age groups, and to surface any age-specific risks hiding inside the averages.

Following PRISMA guidelines, the researchers searched PubMed, Scopus and Web of Science for randomised controlled trials published up to September 2025, then stratified participants into three cohorts: under 30, 30 to 44, and 45 and over. They pooled 28 trials covering 1833 people, analysing body composition, lipid profiles, glycaemic markers and blood pressure. Subgroup analyses compared time-restricted feeding with intermittent energy restriction, and a deliberately conservative sensitivity analysis stress-tested the findings. Risk of bias and the certainty of the evidence were formally assessed.

Intermittent fasting significantly reduced body weight and BMI in every age group, and time-restricted feeding and intermittent energy restriction produced comparable responses. Beyond that, the picture split by age. Young adults saw significant drops in fasting insulin, insulin resistance and fat mass, while middle-aged and older adults gained the most on triglycerides, systolic blood pressure and insulin sensitivity. But fat-free mass fell significantly in both the young and older cohorts, and the conservative analysis unmasked a significant rise in LDL cholesterol in the older group, mirroring a robust LDL rise in young adults. Early middle-aged adults showed highly variable responses with no significant overall cardiometabolic improvement.

This is one of the first attempts to break the intermittent fasting evidence apart by age, and it complicates the simple story that fasting is uniformly good for metabolic health. The weight-loss effect held everywhere, consistent with fasting's reputation, but the lean mass losses and LDL elevations cut against the halo. The authors suggest pairing fasting with adequate protein and resistance training, and call for vigilant lipid monitoring. Crucially, they rate the certainty of the evidence low to very low and frame the age-specific patterns as hypothesis-generating, awaiting validation in larger trials.

If you fast for weight control, the weight result itself looks consistent across ages: it is the surrounding effects that deserve attention. This is a reason to think fasting is not automatically protective for cholesterol, and that lean tissue can go along with the fat, particularly for younger and older adults. It is also a reason not to over-read any of it: the evidence certainty is low, the age patterns are provisional, and what happens to your own lipids or muscle is something only measurement can reveal.